Adam Bentvelzen

Adam Bentvelzen is a Senior Research Associate and Clinical Neuropsychologist at the Vascular Contributions to Dementia Centre of Research Excellence (VCD-CRE), Centre for Healthy Brain Ageing (CHeBA), University of New South Wales. His research focuses on international harmonization of neuropsychological assessment and diagnostic criteria for dementia and cognitive disorders. He has been affiliated with CHeBA since 2017, working under the supervision of Scientia Professor Perminder Sachdev.

Bentvelzen's research examines cognitive aging, neuropsychological assessment methodologies, and vascular contributions to dementia. His work spans:

• Development and validation of cognitive screening tools (e.g., Telephone Interview for Cognitive Status)
• Harmonization of diagnostic criteria for vascular cognitive disorders
• Implementation of cognitive interventions in clinical settings
• Meta-analyses of neurocognitive deficits in neurological disorders

His publications primarily focus on improving dementia assessment through psychometric refinement of tools, international consensus frameworks, and validation studies. Recent work demonstrates strong emphasis on:

• Telehealth-compatible cognitive assessments
• Standardization of diagnostic criteria across research groups
• Implementation science in memory clinics
• Meta-analytic approaches to neurocognitive disorders

Bentvelzen collaborates extensively with national and international research teams on large-scale cohort studies examining CADASIL and other cerebral small vessel diseases. He contributes to WHO initiatives for dementia research standardization and serves as an expert in neuropsychological assessment methodology.